IRIS
IANNONE, ROSA FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 989
AS - Asia 473
EU - Europa 465
Continente sconosciuto - Info sul continente non disponibili 103
SA - Sud America 79
AF - Africa 17
OC - Oceania 2
Totale 2.128
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 970
SG - Singapore 185
RU - Federazione Russa 120
CN - Cina 101
IE - Irlanda 89
HK - Hong Kong 62
BR - Brasile 57
DE - Germania 55
SE - Svezia 55
VN - Vietnam 47
FR - Francia 31
BD - Bangladesh 28
UA - Ucraina 26
IT - Italia 23
FI - Finlandia 17
GB - Regno Unito 13
CA - Canada 10
CZ - Repubblica Ceca 10
IN - India 10
EC - Ecuador 8
AT - Austria 7
MX - Messico 6
NL - Olanda 6
DZ - Algeria 5
IQ - Iraq 5
PK - Pakistan 5
UZ - Uzbekistan 5
PL - Polonia 4
VE - Venezuela 4
AR - Argentina 3
CO - Colombia 3
IR - Iran 3
JP - Giappone 3
LT - Lituania 3
TR - Turchia 3
ZA - Sudafrica 3
AZ - Azerbaigian 2
EG - Egitto 2
KG - Kirghizistan 2
MA - Marocco 2
NP - Nepal 2
SA - Arabia Saudita 2
SN - Senegal 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
ES - Italia 1
GY - Guiana 1
HN - Honduras 1
ID - Indonesia 1
JO - Giordania 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
PW - Palau 1
RO - Romania 1
SC - Seychelles 1
SV - El Salvador 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 2.026
Salva come PNG Salva come JPEG
Città #
Dallas 418
San Jose 179
Dublin 88
Singapore 85
Hong Kong 62
Ashburn 53
Beijing 37
Chandler 34
Nyköping 34
Munich 32
Columbus 29
Santa Clara 25
Council Bluffs 23
Lauterbourg 20
Los Angeles 20
Ho Chi Minh City 18
The Dalles 14
Hanoi 13
Helsinki 13
Jacksonville 13
Moscow 12
Brno 10
Nuremberg 10
New York 8
Chicago 7
Princeton 7
Wilmington 7
London 6
Phoenix 6
Amsterdam 5
Brooklyn 5
Falkenstein 5
Frankfurt am Main 4
Guangzhou 4
Loja 4
Shanghai 4
Tashkent 4
Toronto 4
Turku 4
Xi'an 4
Algiers 3
Atlanta 3
Boston 3
Chennai 3
Guayaquil 3
Hải Dương 3
Mexico City 3
Paris 3
Rio de Janeiro 3
Rome 3
São Paulo 3
Vienna 3
Warsaw 3
Baghdad 2
Baku 2
Caracas 2
Cincinnati 2
Dakar 2
Dhaka 2
Foggia 2
Guiyang 2
Haiphong 2
Hangzhou 2
Hillsboro 2
Islamabad 2
Lahore 2
Milan 2
Montevideo 2
Naples 2
New Delhi 2
Seattle 2
Tokyo 2
Washington 2
Welland 2
Abbotsford British Columbia 1
Abuja 1
Aci Catena 1
Ahmedabad 1
Amman 1
Amparo 1
Andradina 1
Ankara 1
Antalya 1
Araçatuba 1
Arraial do Cabo 1
Aryanah 1
Ash Shuhada' 1
Astrakhan 1
Azcapotzalco 1
Baguio City 1
Balsas 1
Baltimore 1
Bari 1
Batam 1
Belo Horizonte 1
Benoni 1
Bethany 1
Bishkek 1
Blumenau 1
Boardman 1
Totale 1.437
Salva come PNG Salva come JPEG
Nome #
Transthoracic Lung Ultrasound in Systemic Sclerosis-Associated Interstitial Lung Disease: Capacity to Differentiate Chest Computed-Tomographic Characteristic Patterns 196
Nintedanib in Rheumatoid Arthritis–Related Interstitial Lung Disease: Real-World Safety Profile and Risk of Side Effects and Discontinuation 144
Efficacy and retention rate of secukinumab in psoriatic arthritis across different clinical phenotypes: insights from the Italian GISEA Registry 132
Italian Multicenter Real-World Study on the Twelve-Month Effectiveness, Safety, and Retention Rate of Guselkumab in Psoriatic Arthritis Patients 125
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis 114
ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis - A EUSTAR analysis 114
Preliminary data on post market safety profiles of covid 19 vaccines in rheumatic diseases: Assessments on various vaccines in use, different rheumatic disease subtypes, and immunosuppressive therapies: A two-centers study 114
What have multicentre registries across the world taught us about the disease features of systemic sclerosis? 105
Factors predicting early discontinuation of methotrexate as a first-line treatment for rheumatoid arthritis in Italy: Results from the GISEA registry 92
Golimumab effectiveness in biologic inadequate responding patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis in real-life from the Italian registry GISEA 92
Racial differences in systemic sclerosis disease presentation: A European Scleroderma Trials and Research group study 87
Does regression of skin thickening predict improvement of internal organ involvement and survival in patients with diffuse cutaneous systemic sclerosis? A EUSTAR analysis 82
Thoracic lymphadenopathy as possible predictor of the onset of interstitial lung disease in systemic sclerosis patients without lung involvement at baseline visit: A retrospective analysis 82
Arthritis in Systemic Lupus Erythematosus: From 2022 International GISEA/OEG Symposium 74
Survival and prognostic factors from a multicentre large cohort of unselected Italian systemic sclerosis patients 70
Retention rate of a second line with a biologic DMARD after failure of a first-line therapy with abatacept, tocilizumab, or rituximab: results from the Italian GISEA registry 66
Comorbidities in the Spondyloarthritis GISEA Cohort: an average treatment effect analysis on patients treated with bDMARDs 65
Glucocorticoids prescribing practices in systemic sclerosis: an analysis of the EUSTAR database 62
Sex influence on outcomes of patients with systemic sclerosis-associated interstitial lung disease: A EUSTAR database analysis 60
Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research 58
Expert consensus on the treatment of patients with adult-onset still's disease with the goal of achieving an early and long-term remission 57
Effectiveness of ixekizumab over 24 months in different clinical scenarios in psoriatic arthritis: results from the Gruppo Italiano Studio Early Arthritis multicentric prospective registry 56
Real-world effectiveness and persistence of golimumab as second-line anti-TNFα drug in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis patients in Italy: GO-BEYOND, a 12-month prospective observational study 51
Corrigendum to ‘Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: data from the EuroSpA collaboration’ [Seminars in Arthritis and Rheumatism 56 (2022) 1-13/152081] (Seminars in Arthritis and Rheumatism (2022) 56, (S0049017222001329), (10.1016/j.semarthrit.2022.152081)) 25
Beyond screening for pulmonary arterial hypertension: The DETECT score is a potential promising prediction tool for all-cause mortality in systemic sclerosis: Analysis from the EUSTAR database 5
Totale 2.128
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.868
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.868
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202260 0 1 0 0 7 1 0 6 11 24 0 10
2022/2023205 14 11 12 5 9 20 0 22 92 5 13 2
2023/202479 4 3 6 6 8 12 0 1 0 6 7 26
2024/2025352 15 5 4 13 7 53 42 28 78 31 38 38
2025/20261.301 69 147 436 71 37 44 171 104 51 78 38 55
2026/202769 13 56 0 0 0 0 0 0 0 0 0 0
Totale 2.128